Skip to content
Open access

From Identification to Enzymatic Activity Profiling: Comprehensive Characterization of BloCAβ, a Probiotic β‐Carbonic Anhydrase From Bifidobacterium longum

Sep 2026 · Archiv der Pharmazie · Vol 359 · 0 citations · 60 references
Medicine

TL;DR

The first biochemical and functional characterization of β‐class carbonic anhydrase from Bifidobacterium longum (BloCAβ) by inhibition and activation profiles is reported, establishing a biochemical basis for future studies investigating the physiological role of probiotic CAs in bacterial models.

Abstract

The microbiota comprises communities of microorganisms that establish complex relationships with the host and play key roles in physiology, metabolism, and immunity. Increasing evidence highlights microbiota alterations in several diseases, particularly those driven by oxidative stress‐induced inflammation. Thus, identifying probiotic enzymes implicated in essential metabolic pathways is highly relevant to the development of future strategies targeting dysbiosis and related diseases. Herein, we report the first biochemical characterization of β‐class carbonic anhydrase (CA) from Bifidobacterium longum (BloCAβ) by inhibition and activation profiles. The enzyme was recombinantly expressed, purified, and kinetically characterized, displaying a catalytic efficiency within the same order of magnitude as, although lower than, that of human (h)CA I. The functional profile of this novel CA was explored using a panel of commercial sulfonamides, sulfamides, sulfamates, and inorganic/organic anions as inhibitors. Furthermore, several biogenic amines and amino acids were assessed as potential activators of BloCAβ, and their activation profiles were compared with those of hCAs I and II. The cellular effects of selected BloCAβ activators was further evaluated in human macrophages under basal and proinflammatory conditions, while the safety profile was assessed in human intestinal epithelial cells (HIECs). Among them, serotonin (38) was found to significantly enhance cell metabolic activity in both conditions and preserve the metabolic activity of HIECs, further supporting its biocompatibility. Overall, these results provide the first biochemical and functional characterization of BloCAβ and establish a biochemical basis for future studies investigating the physiological role of probiotic CAs in bacterial models.

Read PDF

Similar papers

Sep 2026

Genomic and functional characterization of Limosilactobacillus fermentum DX2034 identifies a probiotic candidate with TLR2-associated anti-adipogenic activity.

Heat-killed DX2034 significantly reduced lipid accumulation, intracellular triglyceride content, and expression of adipogenesis-related genes, including C/EBPα, PPARγ, FABP4, LPL, and FASN, supporting its potential as a functional probiotic or postbiotic candidate.

Do-Young Park, Ji Hyung Kim, Do-Young Park · 0 citations
Open access Sep 2026

Bacteroides cellulosilyticus-derived 2-hydroxyphenylacetic acid rectifies hepatic lipid homeostasis in MASLD by targeting the PPARγ-CD36 axis

The mechanism by which B. cellulosilyticus and 2HPAA alleviate MASLD by targeting the PPARγ-CD36 pathway is revealed, providing a new perspective for the study of gut microbiota-host interactions in regulating liver diseases.

Kaiwei Chen, Zizhen Yang, Ji-Xing Peng et al. · 0 citations
Open access Sep 2026

Genomic and Functional Characterization of Three Probiotic Strains with Features Relevant to Cholesterol and Choline-TMAO Metabolism: Rationale for a Cardiometabolic Formulation

Three strains cover complementary metabolic and surface functions while sharing a safety-relevant feature: none can contribute to TMAO formation, which makes them suitable candidates for a combined cardiometabolic formulation, whose clinical application will be tested in a planned clinical study.

Annalisa Visciglia, Giovanni Deusebio, A. Amoruso et al. · 0 citations
Sep 2026

Novel L-Asparaginases from the human gut microbiome: Genome mining, biochemical characterization, and in vitro anti-leukemic activity.

L-asparaginase is essential for acute lymphoblastic leukemia treatment; however, current Escherichia coli and Erwinia chrysanthemi formulations face significant limitations, including immunogenicity, glutaminase-associated toxicity, and short plasma half-life. The human gut microbiome represents an unexplored reservoir...

Duygu Delican, Ozan Kılıçkaya, Ö. Özden et al. · 0 citations
Open access Sep 2026

Weissella paramesenteroides M4: Optimization of bioprocesses, antioxidant property, and a potentially probiotic strain with in vitro activity against Cutibacterium acnes.

This research provides a sustainable framework for high-yield probiotic production using industrial by-products and introduces a potentially probiotic lactic acid bacterium with selective in vitro activity, representing a promising candidate for alternative acne treatment, addressing a significant gap in current dermat...

Heloísa Carneiro Colares, Tuânia Natacha Lopes Silva, V. Tarabal et al. · 0 citations
Open access Sep 2026

Transcriptomic and Metabolomic Analyses of the Mechanisms Underlying Zearalenone Removal by Lactobacillus paracasei

Zearalenone (ZEN) is a mycotoxin produced by Fusarium species that is harmful to agricultural crops. Therefore, the prevention and control of ZEN contamination is an important concern for food safety. Lactobacillus paracasei 85 is a well-recognized probiotic with considerable potential for mycotoxin biocontrol owing to...

Min Gan, Pei-Rong Chen, Rui Zeng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.